Replies to post #161776 on Biotech Values

[DewDiligence]

Curious timing by ACHN—one day after the announcement of the CEO's "retirement".

[mcbio]

Achillion Nominates ACH-3422 as Nucleotide for the Treatment of Chronic HCV

Since when has ACHN had nuke development capabilities? This is the first time I have heard ACHN reference development of a nuke. Why should we trust that ACHN has the ability to effectively develop a nuke?